Mohamed L. Sorror, MD, MS¹, Theodore A Gooley, PhD^2*, Kirsteen Maclean, PhD^3*, Shamali Roy, PhD^3*, Jesse Hubbard^1*, Mario Marcondes, MD, PhD^1*, Beverly Torok-Storb, PhD^1* and Tewari Muneesh, MD, PhD^4*

¹Fred Hutchinson Cancer Research Center / University of Washington, Seattle, WA
²Clinical Statistics Division, Fred Hutchinson Cancer Research Center, Seattle, WA
³NanoString Technologies, Seattle, WA
⁴University of Michigan, Ann Arbor, MI

Martin Wermke, MD^1*, Julia Eckoldt^2*, Katharina Goetze, MD^3*, Stefan A. Klein⁴, Gesine Bug, MD^5*, Friedrich Stölzel, MD^6*, Malte von Bonin, MD^1*, Johannes Schetelig, MD, M.Sc¹, Michael Laniado, MD^7*, Verena Plodeck, MD^7*, Wolf-Karsten Hofmann, MD⁸, Gerhard Ehninger, MD⁹, Martin Bornhäuser, MD^10*, Dominik Wolf, MD^11*, Igor Theurl, MD, PhD^12* and Uwe Platzbecker, MD¹³

¹Medizinische Klinik I, Universitaetsklinikum C.G.Carus, Dresden, Germany
²Medizinische Klinik I, Universitaetsklinikum C.-G.-Carus, Dresden, Germany
³Technische Universität München, München, Germany
⁴III. Medizinische Klinik, Universitätsmedizin Mannheim, Mannheim, Germany
⁵Department of Medicine, Hematology/Oncology, University of Frankfurt, Frankfurt, Germany
⁶Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus der TU Dresden, Dresden, Germany
⁷Institut und Poliklinik für Radiologische Diagnostik, Universitaetsklinikum C.G.Carus, Dresden, Germany
⁸Department of Hematology and Oncology, Medical Faculty Mannheim of the University of Heidelberg, Mannheim, Germany
⁹Medical Dept. 1, University Hospital TU Dresden, Dresden, Germany
¹⁰Medical Clinic and Policlinic I, Medical Clinic and Policlinic I,, Dresden, Germany
¹¹Department of Internal Medicine III, Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany
¹²Internal Medicine VI, Medical University of Innsbruck, Innsbruck, Austria
¹³Carl Gustav Carus an der Technischen Universität, Universitätsklinikum, Dresden, Germany

Jan J. Cornelissen, MD, PhD¹, Rebecca Wijers^2*, Cornelis A.M. van Bergen^3*, Judith Somers, MD^4*, Eric Braakman, PhD⁵, Jan W. Gratama, MD, PhD⁶, Reno Debets, PhD^7*, J.H. Frederik Falkenburg, MD, PhD³ and Cor Lamers^8*

¹Department of Hematology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands
²Erasmus MC Cancer Institue, department of Medical Oncology, Lab oratory of Tumor Immunology, Erasmus Univeristy medical Center, Rotterdam, Netherlands
³Department of Hematology, Leiden University Medical Center, Leiden, Netherlands
⁴Department of Transfusion Medicine, Sanquin Blood Supply, Rotterdam, Netherlands
⁵Hematology, Erasmus MC, Rotterdam, Netherlands
⁶ErasmusMC Cancer Institute, Department of Medical Oncology, Laboratory of Tumor Immunology, Erasmus MC, Rotterdam, Netherlands
⁷ErasmusMC Cancer Institute, Department of Medical Oncology, Laboratory of Tumor Immunology, ErasmusMC, Rotterdam, Netherlands
⁸ErasmusMC Cacer Institite, Department of Medical Oncology, Laboratory of Tumor Immunology, ErasmusMC, Rotterdam, Netherlands

Mukta Arora, MD¹, Smita Bhatia, MD, MPH², Todd E. DeFor, MS^3*, Manju Nayar^1*, Hewan Belete, medical student^1*, Troy Lund, MD, PhD¹, Bharat Thyagarajan, MD PhD^4*, Celalettin Ustun, MD¹ and Daniel Weisdorf, MD¹

¹Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
²Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
³Adult and Pediatric Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN
⁴Lab Medicine and Pathology, University of Minnesota, Minneapolis, MN

Yi-Bin Chen, MD¹, Jennifer Le-Rademacher, PhD^2*, Deidre Marie Kiefer, MPH^3*, Mehdi Hamadani, MD^2,4, John F. DiPersio, MD, PhD⁵, Mark R Litzow, MD⁶, Michael Craig, MD⁷, Mitchell E. Horwitz, MD⁸, Andrew Artz, MD, MS⁹, Brian McClune, DO¹⁰, Edmund K Waller, MD, PhD¹¹, Hugo F. Fernandez, M.D.¹², Hien Kim Duong, MD¹³, Hati Kobusingye^3*, Mandi Proue, MPH^3*, Rebecca J. Drexler, MPH^3*, Mary M. Horowitz, MD, MS¹⁴, John P. Miller, MD, PhD¹⁵ and Steven M. Devine, MD¹⁶

¹Massachusetts General Hospital, Boston, MA
²CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
³CIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/ Be The Match, Minneapolis, MN
⁴Froedtert Memorial Lutheran Hospital, Milwaukee, WI
⁵Barnes Jewish Hospital, St Louis, MO
⁶Division of Hematology, Mayo Clinic, Rochester, MN
⁷West Virginia University Hospitals, Inc., Morgantown, WV
⁸Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, NC
⁹Section of Hematology/Oncology, Department of Medicine, The University of Chicago Medical Center, Chicago, IL
¹⁰University of Minnesota Medical Center, Fairview, Minneapolis, MN
¹¹Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
¹²Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center, Tampa, FL
¹³Cleveland Clinic Foundation, Cleveland, OH
¹⁴CIBMTR (Center for International Blood & Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
¹⁵National Marrow Donor Program, Minneapolis, MN
¹⁶The Ohio State University, Columbus, OH

Michael J Dugan, MD¹, Drew Winston, MD^2*, Michele I Morris, MD^3*, James E Williams, MD^4*, Natasha Broyde, MS^4* and Pamela Sears, PhD^4*

¹Indiana Blood and Marrow Transplantation, Indianapolis, IN
²UCLA, Los Angeles, CA
³University of Miami, Miami, FL
⁴Merck & Co., Inc., Kenilworth, NJ